Dan Balcauski speaks with Mike Klein, CEO of Genomenon, a genomics intelligence company that combines AI, data, and real-world evidence to create a comprehensive knowledge base for precision therapeutics. Mike discusses his journey in scaling Genomenon, the challenges of selling to scientifically-minded customers, and the strategic shift to a freemium model that led to significant adoption. He highlights the complexities of transitioning from a small to a large team, the importance of delegation, and leveraging board relationships for company growth. Mike also shares insights on maintaining company culture, learning continually, and the invaluable lessons from his mentor.
01:19 Meet Mike Klein, CEO of Genomenon 03:48 Navigating the Genomics Market 10:19 Freemium Model Success 18:20 Delegation and Leadership Insights 26:22 Board Relationships and Governance
Podden och tillhörande omslagsbild på den här sidan tillhör
Dan Balcauski. Innehållet i podden är skapat av Dan Balcauski och inte av,
eller tillsammans med, Poddtoppen.
